| ... |












 |
... |
The
National Cancer Institute, NIH, DHHS, is paving the way for new programs
and discoveries at NCI-Frederick. The HIV Drug Resistance Program (DRP) is a world-class center for
retrovirology research in a highly collaborative environment dedicated purely
to research and supported by a wide spectrum of state-of-the-art core facilities. The emphasis of the DRP is on basic and translational research related to
genetic diversity and drug resistance.
Currently, the DRP is recruiting for the following positions:
Selection
of these positions will be based on merit, without discrimination for nonmerit
reasons such as race, color, religion, gender, national origin, politics,
marital status, physical or mental disability, age, sexual orientation, or
membership or nonmembership in an employee organization. These positions are subject to a background investigation.
Note for Foreign Scientists: Applicants should be aware that the recruitment process is lengthy. Anyone
currently holding a J1 visa and transferring from an academic institution
would be limited to three years from entrance into the United States. For
additional information, please visit the web site of the Fogarty International Center.
The
National Cancer Institute, NIH, DHHS, is an Equal Employment Opportunity
and Affirmative Action employer that values and fosters diversity throughout
the entire organization.
|
... |